The Largest Measles Outbreak, Including 38 Modified Measles and 22 Typical Measles Cases in Its Elimination Era in Yamagata, Japan, 2017

The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genoty...

Full description

Saved in:
Bibliographic Details
Published inJapanese Journal of Infectious Diseases Vol. 71; no. 6; pp. 413 - 418
Main Authors Komabayashi, Kenichi, Seto, Junji, Tanaka, Shizuka, Suzuki, Yu, Ikeda, Tatsuya, Onuki, Noriko, Yamada, Keiko, Ahiko, Tadayuki, Ishikawa, Hitoshi, Mizuta, Katsumi
Format Journal Article
LanguageEnglish
Published Japan National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee 30.11.2018
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genotype D8 occurred in Yamagata Prefecture, Japan, from March to April 2017. This phenomenon was observed after Japan had achieved measles elimination in 2015. We confirmed 60 cases by detecting the genome of the measles virus (MeV). Among the cases, 38 were M-Me and 22 were T-Me. Thirty-nine (65.0%) patients were 20–39 years of age. Three out of 7 primary cases produced 50 transmissions, of which each patient caused 9–25 transmissions. These patients were 22–31 years old and were not vaccinated. Moreover, they developed T-Me and kept contact with the public during their symptomatic periods. Considering that M-Me is generally caused by vaccine failure, some individuals in Japan may have insufficient immunity for MeV. Accordingly, additional doses of measles vaccine may be necessary in preventing measles importation and endemicity among individuals aged 20–39 years. Furthermore, to accurately and promptly diagnose individuals with measles, particularly those who can be considered as primary cases, efforts must be exerted to detect all measles cases using epidemiological and genetic approaches in countries where measles elimination had been achieved.
AbstractList The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genotype D8 occurred in Yamagata Prefecture, Japan, from March to April 2017. This phenomenon was observed after Japan had achieved measles elimination in 2015. We confirmed 60 cases by detecting the genome of the measles virus (MeV). Among the cases, 38 were M-Me and 22 were T-Me. Thirty-nine (65.0%) patients were 20–39 years of age. Three out of 7 primary cases produced 50 transmissions, of which each patient caused 9–25 transmissions. These patients were 22–31 years old and were not vaccinated. Moreover, they developed T-Me and kept contact with the public during their symptomatic periods. Considering that M-Me is generally caused by vaccine failure, some individuals in Japan may have insufficient immunity for MeV. Accordingly, additional doses of measles vaccine may be necessary in preventing measles importation and endemicity among individuals aged 20–39 years. Furthermore, to accurately and promptly diagnose individuals with measles, particularly those who can be considered as primary cases, efforts must be exerted to detect all measles cases using epidemiological and genetic approaches in countries where measles elimination had been achieved.
The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genotype D8 occurred in Yamagata Prefecture, Japan, from March to April 2017. This phenomenon was observed after Japan had achieved measles elimination in 2015. We confirmed 60 cases by detecting the genome of the measles virus (MeV). Among the cases, 38 were M-Me and 22 were T-Me. Thirty-nine (65.0%) patients were 20-39 years of age. Three out of 7 primary cases produced 50 transmissions, of which each patient caused 9-25 transmissions. These patients were 22-31 years old and were not vaccinated. Moreover, they developed T-Me and kept contact with the public during their symptomatic periods. Considering that M-Me is generally caused by vaccine failure, some individuals in Japan may have insufficient immunity for MeV. Accordingly, additional doses of measles vaccine may be necessary in preventing measles importation and endemicity among individuals aged 20-39 years. Furthermore, to accurately and promptly diagnose individuals with measles, particularly those who can be considered as primary cases, efforts must be exerted to detect all measles cases using epidemiological and genetic approaches in countries where measles elimination had been achieved.The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genotype D8 occurred in Yamagata Prefecture, Japan, from March to April 2017. This phenomenon was observed after Japan had achieved measles elimination in 2015. We confirmed 60 cases by detecting the genome of the measles virus (MeV). Among the cases, 38 were M-Me and 22 were T-Me. Thirty-nine (65.0%) patients were 20-39 years of age. Three out of 7 primary cases produced 50 transmissions, of which each patient caused 9-25 transmissions. These patients were 22-31 years old and were not vaccinated. Moreover, they developed T-Me and kept contact with the public during their symptomatic periods. Considering that M-Me is generally caused by vaccine failure, some individuals in Japan may have insufficient immunity for MeV. Accordingly, additional doses of measles vaccine may be necessary in preventing measles importation and endemicity among individuals aged 20-39 years. Furthermore, to accurately and promptly diagnose individuals with measles, particularly those who can be considered as primary cases, efforts must be exerted to detect all measles cases using epidemiological and genetic approaches in countries where measles elimination had been achieved.
Author Onuki, Noriko
Komabayashi, Kenichi
Ikeda, Tatsuya
Ahiko, Tadayuki
Seto, Junji
Suzuki, Yu
Ishikawa, Hitoshi
Mizuta, Katsumi
Tanaka, Shizuka
Yamada, Keiko
Author_xml – sequence: 1
  fullname: Komabayashi, Kenichi
  organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health
– sequence: 2
  fullname: Seto, Junji
  organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health
– sequence: 3
  fullname: Tanaka, Shizuka
  organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health
– sequence: 4
  fullname: Suzuki, Yu
  organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health
– sequence: 5
  fullname: Ikeda, Tatsuya
  organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health
– sequence: 6
  fullname: Onuki, Noriko
  organization: Yamagata Prefecture Division of Health and Welfare Planning
– sequence: 7
  fullname: Yamada, Keiko
  organization: Okitama Public Health Center
– sequence: 8
  fullname: Ahiko, Tadayuki
  organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health
– sequence: 9
  fullname: Ishikawa, Hitoshi
  organization: Shonai Public Health Center
– sequence: 10
  fullname: Mizuta, Katsumi
  organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29962488$$D View this record in MEDLINE/PubMed
BookMark eNp9kb9u2zAQh4UiRfOnfYICBYEuHSyXIimKGgvXSWU4yOIOnYgTRTl0JMolqcFv0McuFTsGmqHLkTh8H3G833VyYQerk-RjhueFEPTrYXjSdr5aVd_nBGdijgV9k1xlQrCUCMov4p0ylnKK2WVy7f0OY5LnGX6XXJKy5IQJcZX82TxqtAa31T6gew2-0x49jKF2Gp5mqLKqGxtjt4gKdD80pjW6OXNgG0QI2hz2RkF3bi_Ax2osqoJHy870xkIwg0VLB1P7F_SwhQAztII92BmK4xfvk7ctdF5_OJ03yc_b5WbxI10_3FWLb-tU5SULKWGaM2iwyAuAtmgF5LTJcsgbXWSatw2uCa45x0ww3tRclXnBYlUcqxYUozfJl-O7ezf8HuOvZW-80l0HVg-jlwRzWmSkpCKin1-hu2F0Nk4nCSEl5kUueKQ-naix7nUj98704A7yZccRKI-AcoP3TrdSmfC8kODAdDLDcspTPucppzzllKeMeUaXvnJfnv-_VR2tnQ-w1WcHXDCq0yenyCSfyj_umVGP4KS29C8Tjb2V
CitedBy_id crossref_primary_10_1016_j_bbmt_2019_04_006
crossref_primary_10_15789_2220_7619_EOA_1407
crossref_primary_10_4274_jcp_2022_82246
crossref_primary_10_1093_infdis_jiz380
crossref_primary_10_3390_ijerph19138017
crossref_primary_10_1016_j_vaccine_2020_05_067
crossref_primary_10_1016_j_vaccine_2024_126257
crossref_primary_10_3390_vaccines12060695
crossref_primary_10_3390_vaccines7030118
crossref_primary_10_22625_2072_6732_2021_13_4_106_112
crossref_primary_10_1016_j_jiac_2019_05_005
crossref_primary_10_1016_j_tmaid_2018_08_006
crossref_primary_10_1016_j_vaccine_2024_126527
crossref_primary_10_3201_eid3005_231757
crossref_primary_10_3928_19382359_20200220_01
crossref_primary_10_46235_1028_7221_16572_DOT
crossref_primary_10_2188_jea_JE20200455
crossref_primary_10_3390_ijms26051801
crossref_primary_10_3390_v13101982
crossref_primary_10_3390_v15010171
crossref_primary_10_7883_yoken_JJID_2018_500
crossref_primary_10_1016_j_jiac_2021_04_006
crossref_primary_10_22141_2312_413X_9_5_6_2021_246693
crossref_primary_10_31631_2073_3046_2019_18_4_34_40
crossref_primary_10_1007_s40278_019_56445_3
crossref_primary_10_1371_journal_pone_0218782
crossref_primary_10_1007_s10654_019_00569_4
crossref_primary_10_1016_j_jiac_2022_03_025
crossref_primary_10_1016_j_ijid_2020_09_1458
crossref_primary_10_1017_S095026881800211X
crossref_primary_10_3390_v14081716
crossref_primary_10_1371_journal_pbio_3001685
crossref_primary_10_1016_j_vaccine_2020_01_067
crossref_primary_10_3389_fmicb_2019_01470
crossref_primary_10_3390_ijerph18010009
crossref_primary_10_3390_v13101970
crossref_primary_10_2807_1560_7917_ES_2024_29_22_2400275
crossref_primary_10_1093_cid_ciz363
Cites_doi 10.1093/infdis/jir098
10.2807/1560-7917.ES.2017.22.42.17-00673
10.1016/j.vaccine.2017.09.026
10.1016/S0140-6736(14)62331-X
10.1093/infdis/jis923
10.5365/wpsar.2015.6.4.007
10.1371/journal.pone.0168222
10.1093/cid/ciu105
10.1002/jmv.21372
10.7883/yoken.63.225
10.1016/j.ijid.2016.10.029
10.7883/yoken.JJID.2005.98
10.1007/s00430-016-0451-4
10.1128/CDLI.11.1.119-122.2004
10.1017/S0950268817001248
ContentType Journal Article
Copyright Authors
Copyright Japan Science and Technology Agency 2018
Copyright_xml – notice: Authors
– notice: Copyright Japan Science and Technology Agency 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
7T7
7TK
7U9
8FD
C1K
FR3
H94
M7N
P64
7X8
DOI 10.7883/yoken.JJID.2018.083
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Virology and AIDS Abstracts
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1884-2836
EndPage 418
ExternalDocumentID 29962488
10_7883_yoken_JJID_2018_083
article_yoken_71_6_71_JJID_2018_083_article_char_en
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
.55
29J
2WC
53G
5GY
ACPRK
ADBBV
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
JSF
JSH
KQ8
OK1
RJT
RNS
RZJ
TR2
W2D
X7M
XSB
AAYXX
CITATION
OVT
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
7T7
7TK
7U9
8FD
C1K
FR3
H94
M7N
P64
7X8
ID FETCH-LOGICAL-c594t-24e64ad0857aaf7f8a53d15a5de71e6fd0b20b6604846db6c95746c9c60cfac43
ISSN 1344-6304
1884-2836
IngestDate Thu Jul 10 22:29:42 EDT 2025
Mon Jun 30 12:01:02 EDT 2025
Thu Jan 02 23:04:04 EST 2025
Tue Jul 01 03:55:13 EDT 2025
Thu Apr 24 22:50:44 EDT 2025
Thu Aug 17 20:30:59 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords primary case
imported measles
elimination era
vaccination
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c594t-24e64ad0857aaf7f8a53d15a5de71e6fd0b20b6604846db6c95746c9c60cfac43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/yoken/71/6/71_JJID.2018.083/_article/-char/en
PMID 29962488
PQID 2229067586
PQPubID 2048383
PageCount 6
ParticipantIDs proquest_miscellaneous_2063712938
proquest_journals_2229067586
pubmed_primary_29962488
crossref_citationtrail_10_7883_yoken_JJID_2018_083
crossref_primary_10_7883_yoken_JJID_2018_083
jstage_primary_article_yoken_71_6_71_JJID_2018_083_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018/11/30
PublicationDateYYYYMMDD 2018-11-30
PublicationDate_xml – month: 11
  year: 2018
  text: 2018/11/30
  day: 30
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Japanese Journal of Infectious Diseases
PublicationTitleAlternate Jpn J Infect Dis
PublicationYear 2018
Publisher National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
Japan Science and Technology Agency
Publisher_xml – name: National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
– name: Japan Science and Technology Agency
References 21. Ching PK, Zapanta MJ, de Los Reyes VC, et al. Investigation of a measles outbreak in Cordillera, Northern Philippines, 2013. Western Pac Surveill Response J. 2016;7:1-5.
22. Zheng X, Zhang N, Zhang X, et al. Correction: investigation of a measles outbreak in China to identify gaps in vaccination coverage, routes of transmission, and interventions. PLoS One. 2016;11:e0168222.
16. Mizuta K, Abiko C, Murata T, et al. An outbreak of measles virus infection due to a genotype D9 at a junior high school in Yamagata, Japan in 2004. Jpn J Infect Dis. 2005;58:98-100.
2. Holzmann H, Hengel H, Tenbusch M, et al. Eradication of measles: remaining challenges. Med Microbiol Immunol. 2016;205:201-8.
4. World Health Organization. Global Measles and Rubella Strategic Plan 2012–2020. Available at <http://apps.who.int/iris/bitstream/10665/44855/1/9789241503396_eng.pdf>. Accessed January 23, 2018.
24. Nagai M, Xin JY, Yoshida N, et al. Modified adult measles in outbreaks in Japan, 2007–2008. J Med Virol. 2009;81:1094-101.
5. World Health Organization Regional Office for the Western Pacific. Brunei Darussalam, Cambodia, Japan verified as achieving measles elimination. Available at <http://www.wpro.who.int/mediacentre/releases/2015/20150327/en/>. Accessed October 2, 2017.
1. Griffin DE. Measles virus. In: Knipe DM, Howley PM, editors. Fields Virology, 6th ed. Philadelphia, PA: Wolters Kluwer; 2013. p.1042-69.
8. Inaida S, Matsuno S, Kobune F. Measles elimination and immunisation: national surveillance trends in Japan, 2008–2015. Epidemiol Infect. 2017;145:2374-81.
25. Akiyoshi K, Suga T, Nukuzuma S, et al. Reevaluation of laboratory methods for diagnosis of measles. Jpn J Infect Dis. 2010;63:225-8.
20. De Serres G, Markowski F, Toth E, et al. Largest measles epidemic in North America in a decade--Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. J Infect Dis. 2013;207:990-8.
7. National Institute of Infectious Diseases. About measles. Updated on June 7, 2017. Available at <https://www.niid.go.jp/niid/ja/kansennohanashi/518-measles.html>. Accessed October 2, 2017. Japanese.
19. Currie J, Davies L, McCarthy J, et al. Measles outbreak linked to European B3 outbreaks, Wales, United Kingdom, 2017. Euro Surveill. 2017;22:42.
17. Hartoyo E, Wiyatno A, Jaya UA, et al. Occurrence of measles genotype D8 during a 2014 outbreak in Banjarmasin, South Kalimantan, Indonesia. Int J Infect Dis. 2017;54:1-3.
23. Quarantine Information Office, Ministry of Health, Labour, and Welfare. Website for travelers’ health. Available at <http://www.forth.go.jp/useful/vaccination.html>. Accessed January 29, 2018. Japanese.
3. World Health Organization. Measles fact sheet, updated in July 2017. Available at <http://www.who.int/mediacentre/factsheets/fs286/en/>. Accessed October 2, 2017.
12. Rosen JB, Rota JS, Hickman CJ, et al. Outbreak of measles among persons with prior evidence of immunity, New York city, 2011. Clin Infect Dis. 2014;58:1205-10.
13. Rota JS, Hickman CJ, Sowers SB, et al. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis. 2011;204:S559-63.
26. Pannuti CS, Morello RJ, Moraes JC, et al. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic. Clin Diagn Lab Immunol. 2004;11:119-22.
15. National Institute of Infectious Diseases. The section of measles in the laboratory manual for pathogen detection, version 3.4. 2017. Avairable at <https://www.niid.go.jp/niid/images/lab-manual/measles.v3-4.2017Mar.pdf>. Accessed September 19, 2017. Japanese.
6. Ministry of Health, Labour and Welfare. The guideline for the prevention of specific infectious diseases: measles. Available at <http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000112477.pdf>. Accessed October 2, 2017. Japanese.
11. Centers for Disease Control and Prevention (CDC). Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th Edition, Chapter 13, Measles. Available at <https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/meas.pdf>. Accessed October 2, 2017.
10. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare. Measles in Japan, 2016. Infect Agents Surveillance Rep. 2017;38:45’-7. Available at <https://www0.niid.go.jp/niid/idsc/iasr/38/445e.pdf>. Accessed January 10, 2018.
14. Katz SL. Measles (Rubeola). In: Gershon AA, Hotez PJ, Katz SL, editors. Krugman’s Infectious Disease of Children. 11th ed. Denvers, CO: Mosby; 2004. p. 353-71.
9. Ministry of Internal Affairs and Communications. Review of the target age for the vaccination of measles. Available at <http://www.soumu.go.jp/main_sosiki/hyouka/pdf/100408_4.pdf>. Accessed December 13, 2017. Japanese.
18. Giesecke J. Primary and index cases. Lancet. 2014;384:2024.
22
23
24
25
26
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – reference: 11. Centers for Disease Control and Prevention (CDC). Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th Edition, Chapter 13, Measles. Available at <https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/meas.pdf>. Accessed October 2, 2017.
– reference: 9. Ministry of Internal Affairs and Communications. Review of the target age for the vaccination of measles. Available at <http://www.soumu.go.jp/main_sosiki/hyouka/pdf/100408_4.pdf>. Accessed December 13, 2017. Japanese.
– reference: 19. Currie J, Davies L, McCarthy J, et al. Measles outbreak linked to European B3 outbreaks, Wales, United Kingdom, 2017. Euro Surveill. 2017;22:42.
– reference: 21. Ching PK, Zapanta MJ, de Los Reyes VC, et al. Investigation of a measles outbreak in Cordillera, Northern Philippines, 2013. Western Pac Surveill Response J. 2016;7:1-5.
– reference: 22. Zheng X, Zhang N, Zhang X, et al. Correction: investigation of a measles outbreak in China to identify gaps in vaccination coverage, routes of transmission, and interventions. PLoS One. 2016;11:e0168222.
– reference: 14. Katz SL. Measles (Rubeola). In: Gershon AA, Hotez PJ, Katz SL, editors. Krugman’s Infectious Disease of Children. 11th ed. Denvers, CO: Mosby; 2004. p. 353-71.
– reference: 6. Ministry of Health, Labour and Welfare. The guideline for the prevention of specific infectious diseases: measles. Available at <http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000112477.pdf>. Accessed October 2, 2017. Japanese.
– reference: 3. World Health Organization. Measles fact sheet, updated in July 2017. Available at <http://www.who.int/mediacentre/factsheets/fs286/en/>. Accessed October 2, 2017.
– reference: 10. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare. Measles in Japan, 2016. Infect Agents Surveillance Rep. 2017;38:45’-7. Available at <https://www0.niid.go.jp/niid/idsc/iasr/38/445e.pdf>. Accessed January 10, 2018.
– reference: 23. Quarantine Information Office, Ministry of Health, Labour, and Welfare. Website for travelers’ health. Available at <http://www.forth.go.jp/useful/vaccination.html>. Accessed January 29, 2018. Japanese.
– reference: 17. Hartoyo E, Wiyatno A, Jaya UA, et al. Occurrence of measles genotype D8 during a 2014 outbreak in Banjarmasin, South Kalimantan, Indonesia. Int J Infect Dis. 2017;54:1-3.
– reference: 7. National Institute of Infectious Diseases. About measles. Updated on June 7, 2017. Available at <https://www.niid.go.jp/niid/ja/kansennohanashi/518-measles.html>. Accessed October 2, 2017. Japanese.
– reference: 15. National Institute of Infectious Diseases. The section of measles in the laboratory manual for pathogen detection, version 3.4. 2017. Avairable at <https://www.niid.go.jp/niid/images/lab-manual/measles.v3-4.2017Mar.pdf>. Accessed September 19, 2017. Japanese.
– reference: 8. Inaida S, Matsuno S, Kobune F. Measles elimination and immunisation: national surveillance trends in Japan, 2008–2015. Epidemiol Infect. 2017;145:2374-81.
– reference: 18. Giesecke J. Primary and index cases. Lancet. 2014;384:2024.
– reference: 12. Rosen JB, Rota JS, Hickman CJ, et al. Outbreak of measles among persons with prior evidence of immunity, New York city, 2011. Clin Infect Dis. 2014;58:1205-10.
– reference: 20. De Serres G, Markowski F, Toth E, et al. Largest measles epidemic in North America in a decade--Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. J Infect Dis. 2013;207:990-8.
– reference: 25. Akiyoshi K, Suga T, Nukuzuma S, et al. Reevaluation of laboratory methods for diagnosis of measles. Jpn J Infect Dis. 2010;63:225-8.
– reference: 24. Nagai M, Xin JY, Yoshida N, et al. Modified adult measles in outbreaks in Japan, 2007–2008. J Med Virol. 2009;81:1094-101.
– reference: 1. Griffin DE. Measles virus. In: Knipe DM, Howley PM, editors. Fields Virology, 6th ed. Philadelphia, PA: Wolters Kluwer; 2013. p.1042-69.
– reference: 4. World Health Organization. Global Measles and Rubella Strategic Plan 2012–2020. Available at <http://apps.who.int/iris/bitstream/10665/44855/1/9789241503396_eng.pdf>. Accessed January 23, 2018.
– reference: 2. Holzmann H, Hengel H, Tenbusch M, et al. Eradication of measles: remaining challenges. Med Microbiol Immunol. 2016;205:201-8.
– reference: 26. Pannuti CS, Morello RJ, Moraes JC, et al. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic. Clin Diagn Lab Immunol. 2004;11:119-22.
– reference: 5. World Health Organization Regional Office for the Western Pacific. Brunei Darussalam, Cambodia, Japan verified as achieving measles elimination. Available at <http://www.wpro.who.int/mediacentre/releases/2015/20150327/en/>. Accessed October 2, 2017.
– reference: 13. Rota JS, Hickman CJ, Sowers SB, et al. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis. 2011;204:S559-63.
– reference: 16. Mizuta K, Abiko C, Murata T, et al. An outbreak of measles virus infection due to a genotype D9 at a junior high school in Yamagata, Japan in 2004. Jpn J Infect Dis. 2005;58:98-100.
– ident: 13
  doi: 10.1093/infdis/jir098
– ident: 19
  doi: 10.2807/1560-7917.ES.2017.22.42.17-00673
– ident: 4
  doi: 10.1016/j.vaccine.2017.09.026
– ident: 18
  doi: 10.1016/S0140-6736(14)62331-X
– ident: 20
  doi: 10.1093/infdis/jis923
– ident: 10
– ident: 14
– ident: 21
  doi: 10.5365/wpsar.2015.6.4.007
– ident: 9
– ident: 7
– ident: 22
  doi: 10.1371/journal.pone.0168222
– ident: 3
– ident: 12
  doi: 10.1093/cid/ciu105
– ident: 5
– ident: 1
– ident: 11
– ident: 24
  doi: 10.1002/jmv.21372
– ident: 25
  doi: 10.7883/yoken.63.225
– ident: 17
  doi: 10.1016/j.ijid.2016.10.029
– ident: 15
– ident: 16
  doi: 10.7883/yoken.JJID.2005.98
– ident: 2
  doi: 10.1007/s00430-016-0451-4
– ident: 26
  doi: 10.1128/CDLI.11.1.119-122.2004
– ident: 6
– ident: 8
  doi: 10.1017/S0950268817001248
– ident: 23
SSID ssj0025510
Score 2.3522854
Snippet The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 413
SubjectTerms Adolescent
Adult
Child
Child, Preschool
Communicable Disease Control - methods
Communicable Diseases, Imported - epidemiology
Communicable Diseases, Imported - pathology
Communicable Diseases, Imported - prevention & control
Communicable Diseases, Imported - transmission
Disease Outbreaks
Disease Transmission, Infectious
elimination era
Epidemics
Epidemiology
Female
Genomes
Genotype
Genotypes
Humans
Immunity
Importation
imported measles
Incidence
Infant
Japan - epidemiology
Male
Measles
Measles - epidemiology
Measles - pathology
Measles - prevention & control
Measles - transmission
Measles Vaccine - administration & dosage
Measles Vaccine - immunology
Measles virus - classification
Measles virus - genetics
Measles virus - isolation & purification
Middle Aged
Outbreaks
primary case
Signs and symptoms
vaccination
Vaccines
Viruses
Young Adult
Title The Largest Measles Outbreak, Including 38 Modified Measles and 22 Typical Measles Cases in Its Elimination Era in Yamagata, Japan, 2017
URI https://www.jstage.jst.go.jp/article/yoken/71/6/71_JJID.2018.083/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/29962488
https://www.proquest.com/docview/2229067586
https://www.proquest.com/docview/2063712938
Volume 71
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Japanese Journal of Infectious Diseases, 2018/11/30, Vol.71(6), pp.413-418
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELe2gRAviG8KAxmJtzaldRwnfYTRsU0MHrZJ21PkJM6WtU2nJXnY_gL-bO5sx2tR-Zp4sdqLHdk5_3x39p2PkHcjPoyEz6THfC49nmVDbyTR0TUHdR2AmaQ6nc_-V7FzxPeOg-O19e0Fr6WmTvrp9cq4kttwFWjAV4yS_QfOupcCAX4Df6EEDkP51zz-gq7cVd3dV7Kaqqr7DQYGiuDEgn_a6KgVP8KsZ0WOCmdbE7fMGeuCJaoZ1ZK3QK5pJ9ndukKvL_SV0ZNkfCmRfCJn8lTW1sf2wmyggoAPl_RcfKCqNuxsaiJWjN9XU-Gdn3gsdHOQNJ_JRF5hYicbLFSkZ4Xb_VG1OR9qynNHPJSlnOhOHJwV183EiZeDBv7p15w0i3saw6i9S7F1-Wj3QZccJlb00o30zwPqjrMCr13RWzKzWVHXSi2s-z7nnvBNJuS-MrQo4h5oX2JRWJh8MRYUiys_NyG1VongRqj8LJ_CKMJ7Mq7mE1X29_Z2P6FvYdQfRP6NOHZOknZaxbp2HA5jgQW2irFVDK3itg6G6AEi1skdBuYSZvL4fOxcncBqNLdytIM0t29hZ96v6MqShnb3HIyUU_Vr-0vrYYcPyQP7-ekH06VHZE2Vj8m9fesi8oR8B1BQCwpq5zRtQdGjDhLUj2gLCVcPIEEZoxYSjqwhQYuSAiToAiQoQALJLSR6VE-THkU4PCVH2-PDrR3Pphvx0mDEa49xJbjMMOWDlHmYRzLws2Egg0yFQyXybJCwQSIEyDwuskSkoyDkUKZikOYy5f4zslHOS_WCUJXwNOFykKLjrsAorEEoUjHK_ITlQOgQ1n7iOLV38WNKmGkMNjnyxTJ9idkd0nONLsxVNL-v_tHwzlW-xYTqkM2W77Fd-KqY6RwRYRCJDnnrHoNYwrNGwCLADl4o_BBtiahDnpv54voBGrBgoDi8_B89fEXu36wgm2SjvmzUa7AT6uSNBsEPx3EXhg
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Largest+Measles+Outbreak%2C+Including+38+Modified+Measles+and+22+Typical+Measles+Cases+in+Its+Elimination+Era+in+Yamagata%2C+Japan%2C+2017&rft.jtitle=Japanese+Journal+of+Infectious+Diseases&rft.au=Komabayashi%2C+Kenichi&rft.au=Seto%2C+Junji&rft.au=Tanaka%2C+Shizuka&rft.au=Suzuki%2C+Yu&rft.date=2018-11-30&rft.pub=National+Institute+of+Infectious+Diseases%2C+Japanese+Journal+of+Infectious+Diseases+Editorial+Committee&rft.issn=1344-6304&rft.eissn=1884-2836&rft.volume=71&rft.issue=6&rft.spage=413&rft.epage=418&rft_id=info:doi/10.7883%2Fyoken.JJID.2018.083&rft.externalDocID=article_yoken_71_6_71_JJID_2018_083_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon